THRD NASDAQ
Third Harmonic Bio, Inc.
1W: +0.0%
1M: -1.3%
3M: +4.3%
1Y: -50.5%
$5.38
Last traded 2025-08-12 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$49K
-40.0% ▼
Operating Income
$59M
+233.9% ▲
Net Income
$45M
+247.5% ▲
EPS (Diluted)
$1.09
+239.7% ▲
EBITDA
-$45M
-47.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $38K | $35K | $0 |
| Gross Profit | $0 | $0 | -$38K | -$35K | -$49K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $10M | $16M | $24M | $24M | $36M |
| SG&A Expenses | $1M | $3M | $13M | $20M | $22M |
| Operating Expenses | $11M | $19M | $38M | $44M | $59M |
| Operating Income | -$11M | -$19M | -$38M | -$44M | $59M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $3M | $0 | $0 |
| Income Before Tax | -$13M | -$30M | -$35M | -$31M | $45M |
| Tax Expense | -$1K | $0 | $3M | $0 | $0 |
| Net Income | -$13M | -$30M | -$38M | -$31M | $45M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.33 | $-0.77 | $-0.89 | $-0.78 | $1.09 |
| EBITDA | -$2M | -$11M | -$35M | -$31M | -$45M |
| Shares Outstanding | 39M | 39M | 39M | 40M | 42M |